Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Urapidil Hcl
2. 64887-14-5
3. Urapidil (hydrochloride)
4. Pvu92pzo12
5. Ncgc00094502-01
6. Ebrantil (tn)
7. Dsstox_cid_25812
8. Dsstox_rid_81149
9. Dsstox_gsid_45812
10. 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride
11. 6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione Hydrochloride
12. 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1h,3h)-pyrimidinedione Monohydrochloride
13. Smr000058525
14. Sr-01000075295
15. Cas-64887-14-5
16. Unii-pvu92pzo12
17. Urapidilhydrochloride
18. Urapidil Hydrochloride,(s)
19. Urapidil Hydrochloride, Solid
20. Mls000758309
21. Mls001424033
22. C20h29n5o3.hcl
23. Schembl1321654
24. Chembl1256716
25. Dtxsid2045812
26. Hy-b0354a
27. Hms1570f12
28. Pharmakon1600-01503100
29. Bcp23389
30. Tox21_111286
31. Tox21_501265
32. Mfcd00078601
33. Nsc758226
34. S2025
35. Akos015994621
36. Tox21_111286_1
37. Ac-8089
38. Ccg-100798
39. H61u751
40. Hs-0064
41. Lp01265
42. Nc00048
43. Nsc-758226
44. Urapidil Hydrochloride [who-dd]
45. Ncgc00016066-14
46. Ncgc00261950-01
47. Eu-0101265
48. Ft-0675734
49. Sw197244-4
50. U-100
51. C76033
52. D08662
53. Sr-01000075295-1
54. Sr-01000075295-3
55. Sr-01000075295-9
56. Q27286781
57. Sr-01000075295-10
58. 6[[3-[4-(o-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil Hydrochloride
59. 2,4(1h,3h)-pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-, Monohydrochloride
60. 6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propylamino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione Hydrochloride
61. 6-[[3-[4-(2-methoxyphenyl)-1-pipera Zinyl]propyl]amino]-1,3-dimethyl-2,4(1h,3h)-pyrimi Dinedione Hydrochloride
62. 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
Molecular Weight | 423.9 g/mol |
---|---|
Molecular Formula | C20H30ClN5O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 423.2037175 g/mol |
Monoisotopic Mass | 423.2037175 g/mol |
Topological Polar Surface Area | 68.4 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 588 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
82
PharmaCompass offers a list of Urapidil Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Urapidil Hydrochloride manufacturer or Urapidil Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Urapidil Hydrochloride manufacturer or Urapidil Hydrochloride supplier.
PharmaCompass also assists you with knowing the Urapidil Hydrochloride API Price utilized in the formulation of products. Urapidil Hydrochloride API Price is not always fixed or binding as the Urapidil Hydrochloride Price is obtained through a variety of data sources. The Urapidil Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Urapidil HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urapidil HCl, including repackagers and relabelers. The FDA regulates Urapidil HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urapidil HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Urapidil HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Urapidil HCl supplier is an individual or a company that provides Urapidil HCl active pharmaceutical ingredient (API) or Urapidil HCl finished formulations upon request. The Urapidil HCl suppliers may include Urapidil HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Urapidil HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Urapidil HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Urapidil HCl active pharmaceutical ingredient (API) in detail. Different forms of Urapidil HCl DMFs exist exist since differing nations have different regulations, such as Urapidil HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Urapidil HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Urapidil HCl USDMF includes data on Urapidil HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Urapidil HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Urapidil HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Urapidil HCl Drug Master File in Japan (Urapidil HCl JDMF) empowers Urapidil HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Urapidil HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Urapidil HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Urapidil HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Urapidil HCl Drug Master File in Korea (Urapidil HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Urapidil HCl. The MFDS reviews the Urapidil HCl KDMF as part of the drug registration process and uses the information provided in the Urapidil HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Urapidil HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Urapidil HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Urapidil HCl suppliers with KDMF on PharmaCompass.
A Urapidil HCl written confirmation (Urapidil HCl WC) is an official document issued by a regulatory agency to a Urapidil HCl manufacturer, verifying that the manufacturing facility of a Urapidil HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Urapidil HCl APIs or Urapidil HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Urapidil HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Urapidil HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Urapidil HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Urapidil HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Urapidil HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Urapidil HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Urapidil HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Urapidil HCl suppliers with NDC on PharmaCompass.
Urapidil HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Urapidil HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Urapidil HCl GMP manufacturer or Urapidil HCl GMP API supplier for your needs.
A Urapidil HCl CoA (Certificate of Analysis) is a formal document that attests to Urapidil HCl's compliance with Urapidil HCl specifications and serves as a tool for batch-level quality control.
Urapidil HCl CoA mostly includes findings from lab analyses of a specific batch. For each Urapidil HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Urapidil HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Urapidil HCl EP), Urapidil HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urapidil HCl USP).